Résumé
Buts
Décrire la prise en charge et le pronostic des hémorragies ulcéreuses gastroduodénales en Côted’Ivoire.
Patients et méthodes
Étude multicentrique (trois centres hospitaliers universitaires du 1er janvier 2010 au 30 septembre 2013). De multiples données cliniques, biologiques et endoscopiques ont été recueillies de façon prospective. Résultats: Quatre-vingt-trois patients ont été recrutés
Résultats
Quatre-vingt-trois patients ont été recrutés (âge moyen: 49 ans; sex-ratio: 5, 4; comorbidités: 5, 4 %; prise d’un anti-inflammatoire non stéroïdien dans 26, 5 % des cas [automédication]). Une transfusion était faite dans 85, 5 % des cas (hémoglobine < 7 g/dl chez 71 patients). Un inhibiteur de la pompe à protons (IPP) a été prescrit chez tous dès l’admission. La gastroscopie (avant 24 heures dans 34, 9 % des cas) a retrouvé un ulcère principalement duodénal (67, 5 %). Le score de Forrest était à III (67 %), celui de Rockall inférieur à 5 (94 %). Aucune hémostase endoscopique n’a été réalisée. Seuls 2, 4 % des patients (tous de stade IIB) ont récidivé. Tous les patients ont été hospitalisés (durée moyenne: sept jours) et ont eu un traitement d’éradication d’Helicobacter pylori (Hp), aucun n’est décédé.
Conclusion
Le traitement essentiellement médical est efficace, les patients étant à faible risque. Nos hôpitaux doivent être équipés en matériel d’hémostase endoscopique pour ceux à haut risque.
Abstract
Aims
To describe management and prognosis of peptic ulcer bleeding in Côte-d’Ivoire.
Patients and methods
This was a multicenter study at three university hospitals from January 1st, 2010 to September 30rd, 2013. Multiple clinical, laboratory, and endoscopic parameters were collected prospectively.
Results
A total of 83 patients (mean age: 49 years; sex ratio: 5.4) were studied. They had comorbidities in 5.4% or used a non-steroidal anti-inflammatory drug in 26.5% of cases (self-medication). Transfusion was made in 85.5% of cases (hemoglobin < 7 g/dl in 71 patients). A proton pump inhibitor was prescribed to all upon admission. Peptic ulcer located in the duodenum was found in 67.5% of cases during gastroscopy (realized before 24 hours in 34.9% of cases). The Forrest classification and the Rockall scores were respectively 3 (67%) and less than 5 (94%). No endoscopic hemostasis was performed. Only 2.4% (N = 2) of patients (all in stage IIB) recurred bleeding ulcer. All patients were hospitalized (average duration of 7 days) and had an eradication of Helicobacter pylori, none died.
Conclusion
The medical treatment is effective when patients are at low-risk. Our hospitals must be equipped in endoscopic hemostasis material for those at high-risk in an emergency unit.
References
Lesur G, Camus M. Comment optimiser la prise en charge endoscopique des hémorragies digestives hautes. Acta Endosc 2015;45:151–5
Sheasgreena C, Leontiadis GI. Recent advances on the management of patients with non-variceal upper gastrointestinal bleeding. Ann Gastroenterol 2013;26:191–7
Nahon S, Hagège H, Latrive JP, et al. Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study. Endoscopy 2012; 44:998–1008
Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med 2008;359:928–37
Sung JJ, Tsoi KK, Ma TK, et al. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10, 428 cases. Am J Gastroenterol 2010;105:84–9
Bagny A, Bouglouga O, Djibril MA, et al. Profil étiologique des hémorragies digestives hautes de l’adulte au CHU campus de Lomé (Togo). J Afr Hepatol Gastroenterol 2012;6:38–42
Ntagirabiri R, Mumana A, Dunduri D, et al. Hémorragie digestive haute de l’adulte au Burundi: aspects épidémiologiques, étiologiques, thérapeutiques et évolutifs. J Afr Hepatol Gastroenterol 2012;6:272–5
Alatise O, Aderibigbe AS, Adisa AO, et al. Management of overt upper gastrointestinal bleeding in a low resource setting: a real world report from Nigeria. BMC Gastroenterol 2014;14:210–5
Diarra M, Soucko-Diarra A, Dolo M, et al. Hémorragies digestives hautes aiguës: expérience d’un milieu rural. Acta Endosc 2007;37:321–6
Alema ON, Martin DO, Okello TR. Endoscopic findings in upper gastrointestinal bleeding patients at Lacor hospital, Northern Uganda. Afr Health Sci 2012;12:518–21
van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 2008;22:209–24
Hreinsson JP, Kalaitzakis E, Gudmundsson S, Björnsson ES. Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting. Scand J Gastroenterol 2013;48:439–47
Loperfido S, Baldo V, Piovesana E, et al. Changing trends in acute upper GI bleeding: a population-based study. Gastrointest Endosc 2009;70:212–24
Jairath V, Kahan BC, Gray A, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 2015;14:61999–1
Cheng HC, Sheu BS. Intravenous proton pump inhibitors for peptic ulcer bleeding: clinical benefts and limits. World J Gastrointest Endosc 2011;3:49–56
van Rensburg CJ, Hartmann M, Thorpe A, et al. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. Am J Gastroenterol 2003;98:2635–41
Al Dhahab H, McNabb-Baltar J, Al-Taweel T, Barkun A. Stateof- the-art management of acute bleeding peptic ulcer disease. Saudi J Gastroenterol 2013;19:195–204
Barkun AN. Should every patient with suspected upper GI bleeding receive a proton pump inhibitor while awaiting endoscopy? Gastrointest Endosc 2008;67:1064–6
Sheasgreena C, Leontiadis GI. Recent advances on the management of patients with non-variceal upper gastrointestinal bleeding. Ann Gastroenterol 2013;26:191–7
Barkun AN, Bardou M, Ernst J. International consensus recommendations on the management of patients with non-variceal upper gastrointestinal bleeding. Ann Intern Med 2010;152:101–13
Adamsen S, Bendix J, Kallehave F, et al. Clinical practice and evidence in endoscopic treatment of bleeding peptic gastroduodenal ulcer. Scand J Gastroenterol 2007;42:318–23
Lanas A, Carrera-Lasfuentes P, García-Rodríguez L, et al. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata: Scand J Gastroenterol 2014;49:1181–90
Lodato F, Azzaroli F, Turco L, et al. Adverse effects of proton pump inhibitors. Best Pract Res Clin Gastroenterol 2010;24: 193–201
Muguruma N, Kitamura S, Kimura T, et al. Endoscopic management of non-variceal upper gastrointestinal bleeding: State of the Art Clin Endosc 2015;48:96–101
Jairath V, Kahan BC, Logan RF, et al. Outcomes following acute non-variceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study. Endoscopy 2012; 44:723–30
Kim JS, Park SM, Kim BW. Endoscopic management of peptic ulcer bleeding. Clin Endosc 2015;48:106–11
Benajah DA, Aqodad N, ElFakir S, et al. Les hémorragies digestives ulcéreuses au CHU Hassan-II de Fès: approche épidémiologique. J Afr Hepatol Gastroenterol 2009;3:16–21
Levin DA, Watermeyer GA, Deetleefs E, et al. The efficacy of endoscopic therapy in bleeding peptic ulcer patients. S Afr Med J 2012;102:290–3
Samlani-Sebbane Z, · Gharaba S, Krati K, et al. Le profil étiologique des hémorragies digestives hautes extériorisées dans la région de Marrakech. J Afr Hepatol Gastroenterol 2012;6:256–8
Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol 2012;107:345–60
Barkun AN, Martel M, Toubouti Y, et al. Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointesc Endosc 2009;69:786–99
Sánchez-Delgado J, Gené E, Suárez D, et al. Has Helicobacter pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression. Am J Gastroenterol 2011;106:398–405
Gisbert JP, Calvet X, Cosme A, et al. Long-term follow-up of 1, 000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding. Am J Gastroenterol 2012; 107:1197–204
Gado AS, Ebeid BA, Abdelmohsen AM, Axon AT. Clinical outcome of acute upper gastrointestinal hemorrhage among patients admitted to a government hospital in Egypt. Saudi J Gastroenterol 2012;18:34–9
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Assi, C., Thot’o, S.A., Diakité, M. et al. Ulcères gastroduodénaux hémorragiques : étude prospective observationnelle multicentrique en Côte-d’Ivoire. Acta Endosc 45, 297–301 (2015). https://doi.org/10.1007/s10190-015-0516-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10190-015-0516-z
Mots clés
- Hémorragie digestive haute
- Ulcère gastroduodénal
- Endoscopie
- Inhibiteur de la pompe à protons
- Transfusion
- Mortalité